| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d313dce6b318f9cc1ab4dcebd2003fdf |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-23 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-23 |
| filingDate |
1988-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1995-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c4e8268a99a08136f01f0772957d415 |
| publicationDate |
1995-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-1335403-C |
| titleOfInvention |
Process and intermediates for lh-rh peptides |
| abstract |
Disclosed herein is an improved process, and inter-mediates therefor, for preparing gonadorelin and certain analogs. The key intermediate is the protected nonapeptide Pyr(W1)-His(W2)-Trp(W3)-Ser(W4)-Tyr(W5)-X1-Leu-Arg(W6)-Pro-OH wherein W1 to w6 inclusive are protective groups and X is Gly, D-2-(naphthylalanyl) or D-Trp(W7) wherein W7 is a protective group. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107176975-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106432427-A |
| priorityDate |
1988-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |